Form 4: Natera Co-Founder Jonathan Sheena Sells Shares Under 10b5-1 Trading Plans

Natera co-founder Jonathan Sheena sold a total of 7,200 shares of common stock on December 18, 2024, through pre-arranged 10b5-1 trading plans.

Summary

• Jonathan Sheena, a co-founder of Natera, Inc., executed multiple sales of Natera common stock on December 18, 2024.
• These sales were conducted under two pre-established Rule 10b5-1 trading plans.
• The first plan was adopted on December 12, 2023, and the second on June 7, 2024.
• A total of 7,200 shares were sold across multiple transactions at varying prices.
• The sales were executed at weighted average prices ranging from $165.9748 to $168.1456 per share for direct sales.
• Indirect sales through the Caraluna 1 and 2 Trusts were executed at weighted average prices ranging from $166.0075 to $168.0445 per share.
• Following these transactions, Sheena directly holds 257,072 shares and indirectly holds 46,282 shares through the Caraluna 1 Trust and 46,282 shares through the Caraluna 2 Trust.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of insider trading under a pre-arranged plan, which is neither positive nor negative in itself. It is a neutral event.

Risks

• Sales by insiders, even under pre-arranged plans, can sometimes be perceived negatively by the market.

Industry Context

Insider trading activity is a common occurrence in publicly traded companies, and these transactions are often pre-planned under Rule 10b5-1 to avoid accusations of trading on non-public information. This filing is a routine disclosure of such activity.

Comparison to Industry Standards

• Sales by insiders are a normal part of the market, and the use of 10b5-1 plans is a standard practice to avoid accusations of insider trading.
• Comparable companies will also have similar filings when insiders sell shares.

Stakeholder Impact

• The sales may have a minor impact on the stock price, but the pre-planned nature of the sales should mitigate any significant negative reaction.

Key Dates

Keywords

Natera, insider trading, Form 4, 10b5-1 trading plan, stock sale, Jonathan Sheena, NTRA